Missed opportunities to manage complex comorbidity of heart failure, type 2 diabetes mellitus and chronic kidney disease: a retrospective cohort study
In overlapping HF, CKD and T2D, guideline-recommended care is suboptimal, with inequalities by age, sex, disease on first presentation and comorbidities. Quality improvement requires linked data collection, monitoring and action across diseases.
Authors
- Laura Pasea (ORCID: https://orcid.org/0000-0001-9374-9691)
- Ashkan Dashtban
- Anish Bhuva (ORCID: https://orcid.org/0000-0001-7532-7815)
- Tamsin Morris (ORCID: https://orcid.org/0000-0003-4475-5483)
- Mamas A. Mamas (ORCID: https://orcid.org/0000-0001-9241-8890)
- Mehrdad A. Mizani (ORCID: https://orcid.org/0000-0002-2441-895X)
- Amitava Banerjee (ORCID: https://orcid.org/0000-0001-8741-3411)
- Jil Billy Mamza (ORCID: https://orcid.org/0000-0001-6240-7525)
- Thomas W. Oates (ORCID: https://orcid.org/0000-0001-6435-1326)
- Mohamed Mohamed
- Sarah Ali (ORCID: https://orcid.org/0000-0002-8138-3028)
Institutions
- AstraZeneca (United Kingdom) (GB)
- Barts Health NHS Trust (GB)
- The Royal Free Hospital (GB)
- University of Manchester (GB)
- British Heart Foundation (GB)
- University College London (GB)
Publication Details
- Journal
- Heart
- Published
- 2025-03-04
- DOI
- https://doi.org/10.1136/heartjnl-2024-325046
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.88
Funders
- AstraZeneca
- Barts Charity
- National Institute for Health and Care Research
- British Heart Foundation